Artiva (ARTV) CMO Subhashis Banerjee Sells 1,100 Shares

What Happened

• Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics (ARTV), disposed of 1,100 shares on September 3, 2026. The shares were sold at $11.16 per share for total proceeds of $12,271. The Form 4 lists the transaction as a sale (code S).

Key Details

• Transaction date and price: 2026-09-03, 1,100 shares at $11.16 each.
• Proceeds: $12,271.
• Shares owned after transaction: Not disclosed in the information provided in this summary.
• Notable footnote: The sale was a "sell-to-cover" to satisfy tax withholding obligations tied to the vesting and release of restricted stock units (RSUs). The sale was automatic and not at the reporting person’s discretion (Footnote F1).
• Timeliness: Form 4 filed 2026-09-04 (timely under Form 4 rules).

Context

• A sell-to-cover is a routine administrative sale used to pay taxes when RSUs vest; such transactions generally do not signal the insider’s view on the company’s prospects. The small size of the sale ($12k) suggests it was solely for tax withholding rather than a broader cashing-out event.